Scarica l'app Stockscreener
543.84
0.91%
4.92
Dopo l'orario di chiusura:
543.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$538.92
Aprire:
$541
Volume 24 ore:
1.57M
Relative Volume:
0.69
Capitalizzazione di mercato:
$205.36B
Reddito:
$43.21B
Utile/perdita netta:
$6.58B
Rapporto P/E:
31.48
EPS:
17.2769
Flusso di cassa netto:
$6.17B
1 W Prestazione:
+3.67%
1M Prestazione:
+13.40%
6M Prestazione:
+27.21%
1 anno Prestazione:
-9.62%
Intervallo 1D:
$540.00
$550.46
Intervallo di 1 settimana:
$519.45
$550.46
Portata 52W:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
543.84 | 203.50B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
208.39 | 149.70B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
643.41 | 50.83B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
143.00 | 40.23B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.05 | 34.77B | 15.70B | 1.24B | 2.01B | 6.9036 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock survive global slowdownLong Setup & Free Safe Capital Growth Stock Tips - nchmf.gov.vn
U.S. Drug Screening Market Size to Envision USD 3.84 Billion by 2034 - GlobeNewswire Inc.
BofA Adjusts Price Target on Thermo Fisher Scientific to $610 From $560 - MarketScreener
Aug PostEarnings: Will Thermo Fisher Scientific Inc. (TN8) stock outperform benchmarksJuly 2025 Institutional & Community Verified Watchlist Alerts - nchmf.gov.vn
Escherichia Coli Strain Market Booming with Rapid Growth - openPR.com
Is it time to cut losses on Thermo Fisher Scientific Inc.Weekly Stock Report & High Accuracy Trade Alerts - newser.com
How Thermo Fisher Scientific Inc. (TN8) stock reacts to stronger dollar2025 Support & Resistance & Entry Point Strategy Guides - nchmf.gov.vn
Is Thermo Fisher Scientific Inc. stock ready for breakoutJuly 2025 Levels & Fast Gain Swing Trade Alerts - nchmf.gov.vn
Why Thermo Fisher Scientific Inc. stock is a value investor pickJuly 2025 Trends & Verified Chart Pattern Signals - nchmf.gov.vn
Why Thermo Fisher Scientific Inc. stock appeals to analysts2025 Buyback Activity & Risk Managed Trade Strategies - nchmf.gov.vn
Treasury Yields: What risks investors should watch in Thermo Fisher Scientific Inc. stockWeekly Market Summary & Precise Entry and Exit Recommendations - nchmf.gov.vn
Aug Sentiment: Will Thermo Fisher Scientific Inc. stock outperform growth indexesDay Trade & Growth Focused Investment Plans - nchmf.gov.vn
What valuation ratios show for Thermo Fisher Scientific Inc. (TN8) stockDay Trade & Safe Capital Allocation Plans - Trung tâm Dự báo KTTV quốc gia
OpenAI and Thermo Fisher Scientific in Life Sciences Collaboration - Inside HPC
Volatility clustering patterns for Thermo Fisher Scientific Inc.July 2025 Retail & Risk Adjusted Buy/Sell Alerts - newser.com
What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation - Yahoo Finance
Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now? - The Globe and Mail
EPS Watch: Will Thermo Fisher Scientific Inc. stock outperform growth indexes2025 Market Outlook & High Yield Equity Trading Tips - nchmf.gov.vn
Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics - Yahoo Finance
Fund Update: E. Ohman J:or Asset Management AB added 18,686 shares of THERMO FISHER SCIENTIFIC (TMO) to their portfolio - Quiver Quantitative
PFAS Testing Market Outlook, 2037 - GlobeNewswire Inc.
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI - BioSpace
J.P. Morgan Raises PT on Thermo Fisher Scientific (TMO) Keeps an Overweight Rating - Insider Monkey
Thermo Fisher Scientific Forms Collaboration With OpenAI to Accelerate Drug Development - 富途牛牛
Thermo Fisher to collaborate with OpenAI to speed drug discovery - R&D World
Thermo Fisher Integrates OpenAI To Speed Drug Development - Benzinga
Deutsche Bank Adjusts Thermo Fisher Scientific Price Target to $530 From $520, Maintains Buy Rating - MarketScreener
Thermo Fisher taps OpenAI tech for drug development - The Business Journals
Is Thermo Fisher a Smart Play After 11% Rally and Positive Sector News? - simplywall.st
Thermo Fisher Scientific announces strategic collaboration with OpenAI📱 - XTB.com
TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus - TradingView
Thermo Fisher stock rises as company unveils OpenAI collaboration By Investing.com - Investing.com Nigeria
Thermo Fisher taps Microsoft-backed OpenAI to speed up innovation - Seeking Alpha
Thermo Fisher stock rises as company unveils OpenAI collaboration - Investing.com
Thermo Fisher Scientific Launches Next-Generation Microarray Solution - World Business Outlook
Healthcare CMO Analysis Report 2025: Market to Reach $291.25 Billion by 2029, Driven by Catalent, Samsung Biologics, and Thermo Fisher Scientific - Yahoo Finance
Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution - Business Wire
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Baird Raises Price Target on Thermo Fisher Scientific to $628 From $567, Maintains Outperform Rating - MarketScreener
Using Bollinger Bands to evaluate Thermo Fisher Scientific Inc.Gold Moves & Reliable Entry Point Alerts - newser.com
Is Thermo Fisher Scientific Attractively Priced After Recent $3.1 Billion Olink Acquisition? - Yahoo Finance
Polen Focus Growth Strategy Sold Thermo Fisher Scientific (TMO) to Fund Other Investments - Insider Monkey
From street to lab: Advancing controlled substance testing with handheld Raman and FTIR - News-Medical
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $612 From $550, Maintains Buy Rating - MarketScreener
$1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today - Sahm
Understanding Thermo Fisher Scientific Inc.’s price movementOil Prices & Smart Swing Trading Alerts - newser.com
Dr. Park CDMO Selects Thermo Fisher Scientific To Equip New Viral Vector Manufacturing Facility - Technology Networks
Franklin Street Loads Up on Thermo Fisher Scientific (NASDAQ:TMO): Becomes 8th Largest Holding - The Motley Fool
Leerink Partners Adjusts Thermo Fisher Scientific Price Target to $545 From $500, Maintains Outperform Rating - MarketScreener
Yousif Capital Management LLC Lowers Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (TMO) Stock Analysis: A 5.59% Upside Potential In Healthcare Diagnostics - DirectorsTalk Interviews
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
1.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):